Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency

Brain

Volumn 130, Issue 7, 2007, Pages 1905-1920

  Strauss, Kevin A ^a   Lazovic, Jelena ^b   Wintermark, Max ^c   Morton, D Holmes ^a  

^a CLINIC FOR SPECIAL CHILDREN   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral metabolism; Diffusion; Glutaric aciduria type 1; Perfusion; Striatal necrosis

Indexed keywords

AMINO ACID; CARNITINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INFUSION FLUID; LYSINE; TRYPTOPHAN; GLUTARYL COENZYME A DEHYDROGENASE;

AMISH; ARTICLE; BASAL GANGLION; BLOOD VOLUME; BRAIN DEGENERATION; BRAIN INJURY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORPUS STRIATUM; CYTOTOXICITY; DIET THERAPY; DIETARY INTAKE; DISEASE PREDISPOSITION; EDEMA; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; GLUCOSE TRANSPORT; GLUTARYL COENZYME A DEHYDROGENASE DEFICIENCY; GRAY MATTER; HOMOZYGOSITY; HUMAN; INFANT; MALE; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRIATE CORTEX; ACUTE DISEASE; CHRONIC DISEASE; DEVELOPMENTAL DISORDER; DIFFUSION WEIGHTED IMAGING; ENZYMOLOGY; GENETICS; METABOLIC ENCEPHALOPATHY; METHODOLOGY; MUTATION; NECROSIS; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR DISORDER; RETROSPECTIVE STUDY;

ACUTE DISEASE; BRAIN DISEASES, METABOLIC, INBORN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CORPUS STRIATUM; DEVELOPMENTAL DISABILITIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLUTARYL-COA DEHYDROGENASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTOR SKILLS DISORDERS; MUTATION; NECROSIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447619892     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm058     Document Type: Article

References (57)

1. Albers GW. Diffusion-weighted MRI for evaluation of acute stroke. Neurology 1998; 51: S47-9.
2. Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Lim I, et al. Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 2006; 37: 1211-6.
3. Auer RN, Sutherland GR. Hypoxia and related conditions. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. (Vol. 1): London: Arnold; 2002. p. 233-80.
4. Ayata C, Ropper AH. Ischaemic brain oedema. J Clin Neurosci 2002; 9: 113-24.
5. Barkovich AJ, Miller SP, Bartha A, Newton N, Hamrick SE, Mukherjee P, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 2006; 27: 533-47.
6. Bristow MS, Simon JE, Brown RA, Eliasziw M, Hill MD, Coutts SB, et al. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005; 25: 1280-7.
7. Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, et al. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 1998; 70: 794-805.
8. Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 1995; 92: 7105-9.
9. Brownell AL, Chen YI, Yu M, Wang X, Dedeoglu A, Cicchetti F, et al. 3-Nitropropionic acid-induced neurotoxicity-assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. J Neurochem 2004; 89: 1206-14.
10. Calabresi P, Centonze D, Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology 2000; 55: 1249-55.
11. Chow CW, Haan EA, Goodman SI, Anderson RM, Evans WA, Kleinschmidt- DeMasters BK, et al. Neuropathology in glutaric acidaemia type 1. Acta Neuropathol (Berl) 1988; 76: 590-4.
12. Chyi T, Chang C. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience 1999; 92: 1035-41.
13. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Philadelphia: Lippincott-Raven; 1999. p. 637-70.
14. Edelman G, Hoffman WE. Cerebral venous and tissue gases and arteriovenous shunting in the dog. Anesth Analg 1999; 89: 679-83.
15. Erecinska M, Cherian S, Silver IA. Energy metabolism in mammalian brain during development. Prog Neurobiol 2004; 73: 397-445.
16. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002; 33: 79-86.
17. Funk CB, Prasad AN, Frosk P, Sauer S, Kolker S, Greenberg CR, et al. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 2005; 128: 711-22.
18. Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001; 186 (Suppl 1): S15-23.
19. Haas RH, Marsden DL, Capistrano-Estrada S, Hamilton R, Grafe MR, Wong W, et al. Acute basal ganglia infarction in propionic acidemia. J Child Neurol 1995; 10: 18-22.
20. Hamilton BF, Gould DH. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol (Berl) 1987; 72: 286-97.
21. Hassel B, Brathe A, Petersen D. Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate. J Neurochem 2002; 82: 410-9.
22. Hoffmann GF, Gibson KM, Trefz FK, Nyhan WL, Bremer HJ, Rating D. Neurological manifestations of organic acid disorders. Eur J Pediatr 1994; 153: S94-100.
23. Hudetz AG. Blood flow in the cerebral capillary network: a review emphasizing observations with intravital microscopy. Microcirculation 1997a; 4: 233-52.
24. Hudetz AG. Regulation of oxygen supply in the cerebral circulation. Adv Exp Med Biol 1997b; 428: 513-20.
25. Ironside JW, Pickard JD. Raised intracranial pressure, oedema, and hydrocephalus. In: Graham DI, Lantos PL, editors. Greenfield's Neuropathology. (Vol. 1): London: Arnold; 2002. p. 193-232.
26. Ito U, Kuroiwa T, Hanyu S, Hakamata Y, Kawakami E, Nakano I, et al. Temporal profile of experimental ischemic edema after threshold amount of insult to induce infarction-ultrastructure, gravimetry and Evans' blue extravasation. Acta Neurochir Suppl 2003; 86: 131-5.
27. Kolker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 2006; 59: 840-7.
28. Kolker S, Hoffmann GF, Schor DS, Feyh P, Wagner L, Jeffrey I, et al. Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 2003; 34: 253-60.
29. Lansberg MG, Thijs VN, O'Brien MW, Ali JO, de Crespigny AJ, Tong DC, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol 2001; 22: 637-44.
30. Martinez-Lage JF. Neurosurgical treatment for hydrocephalus, subdural hematomas, and arachnoid cysts in glutaric aciduria type 1. Neuropediatrics 1996; 27: 335-6.
31. Morris AA, Hoffmann GF, Naughten ER, Monavari AA, Collins JE, Leonard JV. Glutaric aciduria and suspected child abuse. Arch Dis Child 1999; 80: 404-5.
32. Morton DH, Bennett MJ, Seargeant LE, Nichter CA, Kelley RI. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Genet 1991; 41: 89-95.
33. Morton DH, Morton CS, Strauss KA, Robinson DL, Puffenberger EG, Hendrickson C, et al. Pediatric medicine and the genetic disorders of the Amish and Mennonite people of Pennsylvania. Am J Med Genet C Semin Med Genet 2003; 121: 5-17.
34. Nagesh V, Welch KM, Windham JP, Patel S, Levine SR, Hearshen D, et al. Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke 1998; 29: 1778-82.
35. Nehlig A. Cerebral energy metabolism, glucose transport and blood flow: changes with maturation and adaptation to hypoglycaemia. Diabetes Metab 1997; 23: 18-29.
36. Pranevicius M, Pranevicius O. Cerebral venous steal: blood flow diversion with increased tissue pressure. Neurosurgery 2002; 51: 1267-73; discussion 1273-4.
37. Puffenberger EG. Genetic heritage of the Old Order Mennonites of Southeastern Pennsylvania. Am J Med Genet Part C (Semin Med Genet) 2003; 121C: 18-31.
38. Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998; 4: 99-107.
39. Riepe MW, Hori N, Ludolph AC, Carpenter DO. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience 1995; 64: 91-7.
40. Rodriguez-Nunez A, Cid E, Eiris J, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, et al. Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children. Brain Dev 1999; 21: 16-9.
41. Rohl L, Ostergaard L, Simonsen CZ, Vestergaard-Poulsen P, Andersen G, Sakoh M, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001; 32: 1140-6.
42. Sakoh M, Ohnishi T, Ostergaard L, Gjedde A. Prediction of tissue survival after stroke based on changes in the apparent diffusion of water (cytotoxic edema). Acta Neurochir Suppl 2003; 86: 137-40.
43. Sakoh M, Ostergaard L, Rohl L, Smith DF, Simonsen CZ, Sorensen JC, et al. Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs. J Neurosurg 2000; 93: 647-57.
44. Sauer SW, Okun JG, Fricker G, Mahringer A, Muller I, Crnic LR, et al. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 2006.
45. Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, et al. Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 2005; 280: 21830-6.
46. Schmithorst VJ, Dardzinski BJ, Holland SK. Simultaneous correction of ghost and geometric distortion artifacts in EPI using a multiecho reference scan. IEEE Trans Med Imaging 2001; 20: 535-9.
47. Shockley RP, LaManna JC. Determination of rat cerebral cortical blood volume changes by capillary mean transit time analysis during hypoxia, hypercapnia and hyperventilation. Brain Res 1988; 454: 170-8.
48. Strauss KA. Glutaric aciduria type 1: a clinician's view of progress. Brain 2005; 128: 697-9.
49. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 2003; 121: 38-52.
50. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213: 521-5.
51. Ursino M, Giulioni M, Lodi CA. Relationships among cerebral perfusion pressure, autoregulation, and transcranial Doppler waveform: a modeling study. J Neurosurg 1998; 89: 255-66.
52. Walker PM, Ben Salem D, Lalande A, Giroud M, Brunotte F. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004; 220: 23-8.
53. Wang GJ, Volkow ND, Overall J, Hitzemann RJ, Pappas N, Pascani K, et al. Reproducibility of regional brain metabolic responses to lorazepam. J Nucl Med 1996; 37: 1609-13.
54. Wintermark M, Lepori D, Cotting J, Roulet E, van Melle G, Meuli R, et al. Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography. Pediatrics 2004; 113: 1642-52.
55. Wintermark M, Thiran JP, Maeder P, Schnyder P, Meuli R. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001; 22: 905-14.
56. Yeung HW, Sanches A, Squire OD, Macapinlac HA, Larson SM, Erdi YE. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter. Eur J Nucl Med Mol Imaging 2002; 29: 61-6.
57. Zinnanti WJ, Lazovic J, Wolpert EB, Antonetti DA, Smith MB, Connor JR, et al. A diet-induced mouse model for glutaric aciduria type I. Brain 2006.